The global ultrasound devices market is poised for robust growth from 2025 to 2035, driven by the rapid rise of portable and handheld systems, AI-enhanced imaging, and expanding applications in cardiology, radiology, and obstetrics. With a projected CAGR of 5.8–7.3%, the market is expected to surpass $16–18 billion by 2032, led by innovations in 3D/4D and Doppler technologies. North America continues to dominate revenue share, while Asia-Pacific emerges as the fastest-growing region due to increasing healthcare infrastructure and point-of-care demand. Key players like GE HealthCare, Philips, and Siemens are accelerating competition through AI integration and strategic acquisitions, signaling a transformative decade for accessible, non-invasive diagnostics worldwide.